Transcranial magnetic stimulation (TMS), an FDA approved treatment for major depression, is a noninvasive procedure which uses magnetic fields to stimulate specific areas of the brain. It is not commonly used as a first [...]
If sleep disturbance is the harbinger of perinatal anxiety and OCD, it might make sense to place more emphasis on this symptom.
It is great to see so many well-written and researched reports on perinatal depression in the news these days. Here are a few great stories from NPR published over the last couple of months. [...]
Programs are necessary to implements strategies for reducing the risk of suicide and infanticide in postpartum women, especially in women at risk for postpartum psychosis.Â
In the United States, about one out of every 160 pregnancies ends in stillbirth, defined as a pregnancy loss occurring after 20 weeks’ gestation. Perinatal loss is a traumatic event for women and their [...]
The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standard, [...]
While we have been talking about using brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant - SAGE 217 or zuranolone - has [...]
Smoking is relatively common during pregnancy, with about 10% of all women smoking at some point during their pregnancy. The rates are even higher among women with psychiatric illness. While many women may be [...]
For women, the postpartum period appears to be a time of increased risk for conversion to bipolar disorder in women previously diagnosed with major depressive disorder. Sharma and colleagues observed that the rate of diagnostic [...]
Depressive symptoms were assessed in a group of 622 Canadian first-time fathers during their partner’s third trimester using the Edinburgh Postnatal Depression Scale (EPDS). The prevalence of depressive symptoms in fathers was 13.76% at 2 [...]
